Literature DB >> 22075581

Necrotizing fasciitis and septic shock related to the uncommon gram-negative pathogen Sphingobacterium multivorum.

D Grimaldi1, A Doloy, J Fichet, E Bourgeois, B Zuber, A Wajsfisz, J P Mira, C Poyart, F Pène.   

Abstract

We report the first case of necrotizing fasciitis due to the uncommon Gram-negative pathogen Sphingobacterium multivorum in an immunocompromised patient, who presented with septic shock. This case adds necrotizing fasciitis to the spectrum of S. multivorum-related infections and highlights the emergence of Gram-negative bacteria in severe soft tissue infections.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22075581      PMCID： PMC3256725          DOI： 10.1128/JCM.05151-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Cellulitis and sepsis due to sphingobacterium.

Authors:  Mark A Marinella
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

2.  Sphingobacterium multivorum isolated from a patient with cystic fibrosis.

Authors:  J Reina; N Borrell; J Figuerola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

Review 3.  Necrotizing soft-tissue infection: diagnosis and management.

Authors:  Daniel A Anaya; E Patchen Dellinger
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

4.  Septicemia caused by Sphingobacterium multivorum.

Authors:  J Freney; W Hansen; C Ploton; H Meugnier; S Madier; N Bornstein; J Fleurette
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

5.  Unusual "flesh-eating" strain of Escherichia coli.

Authors:  David Grimaldi; Stéphane Bonacorsi; Hélène Roussel; Benjamin Zuber; Hélène Poupet; Jean-Daniel Chiche; Claire Poyart; Jean-Paul Mira
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

6.  Flavobacterium multivorum septicemia in a hemodialyzed patient.

Authors:  C Potvliege; C Dejaegher-Bauduin; W Hansen; M Dratwa; F Collart; C Tielemans; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

Review 7.  Serious infections with antirheumatic therapy: are biologicals worse?

Authors:  K L Winthrop
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

8.  Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease.

Authors:  R Manfredi; A Nanetti; M Ferri; A Mastroianni; O V Coronado; F Chiodo
Journal:  J Infect       Date:  1999-09       Impact factor: 6.072

9.  Bacteremia caused by a novel species of Sphingobacterium.

Authors:  H Tronel; P Plesiat; E Ageron; P A D Grimont
Journal:  Clin Microbiol Infect       Date:  2003-12       Impact factor: 8.067

10.  Sphingobacterium respiratory tract infection in patients with cystic fibrosis.

Authors:  Antonietta Lambiase; Fabio Rossano; Mariassunta Del Pezzo; Valeria Raia; Angela Sepe; Fabiola de Gregorio; Maria Rosaria Catania
Journal:  BMC Res Notes       Date:  2009-12-23
View more
  4 in total

1.  The first Korean case of Sphingobacterium spiritivorum bacteremia in a patient with acute myeloid leukemia.

Authors:  Young Rae Koh; Shine Young Kim; Chulhun L Chang; Ho-Jin Shin; Kye-Hyung Kim; Jongyoun Yi
Journal:  Ann Lab Med       Date:  2013-06-24       Impact factor: 3.464

2.  Septic arthritis by Sphingobacterium multivorum in imunocompromised pediatric patient.

Authors:  Maiana Darwich Mendes; Rafael Ruiz Cavallo; Cecilia Helena Vieira Franco Godoy Carvalhães; Maria Aparecida Gadiani Ferrarini
Journal:  Rev Paul Pediatr       Date:  2016-02-01

3.  Sphingobacterium multivorum: case report and literature review.

Authors:  F Barahona; J Slim
Journal:  New Microbes New Infect       Date:  2015-05-16

4.  Sphingobacterium multivorum: An Atypical Bacterium in an Atypical Place.

Authors:  Hadrián Pernas-Pardavila; Aldara M Vallejo-Alonso; Ignacio Novo-Veleiro; Daniel Navarro de la Cruz; Arturo González-Quintela
Journal:  Eur J Case Rep Intern Med       Date:  2019-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.